By reprogramming human fibroblasts into pluripotent stem cells with somatic cell nuclear transfer, scientists have come up with a viable alternative to iPSCs.
By reprogramming human fibroblasts into pluripotent stem cells with somatic cell nuclear transfer, scientists have come up with a viable alternative to iPSCs.
A surgeon sues the Nobel Assembly for excluding him from last year’s prize awarded for regenerative science, but stem cell scientists are skeptical of his claims.
A study suggests that some mouse models do not accurately mimic human molecular mechanisms of inflammatory response, but other mouse strains may fare better.
Tuberculosis bacteria find shelter from drugs and the body’s defenses in bone marrow stem cells.
Scientists use virus-free gene therapy on patient-derived stem cells to repair spinal muscular atrophy in mice.
Researchers and biotech companies are bringing a universal flu vaccine closer to reality.
Reprogrammed stem cells are not attacked by the immune system, or are they?
Autism researchers are testing the ability of whipworm eggs to treat autism in a new clinical trial.
Two former Geron CEOs make a bid for the company’s defunct human embryonic stem cell business.
Inflammatory signals in injured zebrafish brains promote the growth of new neurons.